At some point, you gotta just laugh.
Because actually, the success of this service is unreal.
Fast5 has been live for 11 weeks, and 10 – TEN, PEOPLE! – of these alerts have been stone cold winning trades in 5 days or less.
Today’s was no exception.
The one loser? A measly 7% where we tactfully stopped out and preserved the maximum amount of capital.
FAST5 Trade Alerts – Here’s the full week-by-week breakdown.
Week One: +11% in I
Week Two: +25% in SRRA
Week Three: +28% in VSTM
Week Four: +38% in DMPI
Week Five: +14% in XXII
Week Six: +23% in LJPC
Week Seven: +7% in NOK
Week Eight: +50% in BB
Week Nine: +15% in PRTY
Week Ten: -7% in PLUG
Week Eleven: DETAILS BELOW — +33% in AEMD
Let’s dive into today’s trade in AEMD.
Here’s the exact email that went out to my Fast5 members this morning:
I send you this to show you exactly how easy this is to execute.
I not only give you a “BUY price,” but a BUY ZONE.
This way, you know exactly what range I’m comfortable owning the stock in.
Same for my Profit Zone and Stop Zone.
I make it a habit to go the extra mile for my members!
Between the time I sent out this paid alert this morning on AEMD and now (frankly, a matter of hours…), the stock price spiked up 33%.
I’ve spent years honing my stock selection skills, and I’ve developed a system that helps me spot weekly winners just like AEMD.
But here’s what you have to understand.
Stock selection is barely ⅓ of the battle.
Sure you need it to get your feet off the ground, but then I help you walk all the way to the bank…
Buy Zone – Stop Zone – Profit Zone – Trade Plan
I do all the heavy lifting, and all you have to do is plug and play…
Be Advised!
Fast 5 Trading Alerts Week 13 Results coming soon….
Next week I will alert Week 13’s Fast 5 trade.
You saw my *nearly – damn you, PLUG!* spotless track record, and I know you can put 2 and 2 together… it’s 4. And next week’s trade has these odds in its favor.
You do the math.
[Ed.note: Kyle Dennis runs BiotechBreakouts.com. He is an event-based trader, who prefers low-priced and small-cap biotech stocks.